Abstract Oxidative stress has been documented in tissues and biofluids of subjects with sporadic Alzheimer disease (AD) and mild cognitive impairment (MCI). The aim of this study was to determine whether (a) salivary protein carbonyls are elevated in AD and MCI subjects, (b) salivary protein carbonyl contents in these groups exhibit diurnal variation, and (c) apolipoprotein E ɛ4 (apoE ɛ4) carrier status impacts salivary carbonyl concentrations or rhythmicity in the AD and MCI cohorts. Unstimulated saliva was collected at fixed intervals between 8 AM and 10 PM from 15 AD subject , 21 MCI subjects, and 30 cognitively-intact controls. Salivary protein carbonyl concentrations were measured by ELISA. ApoE genotyping was performed on the AD and MCI individuals. For all groups, mean protein carbonyl contents were significantly elevated at 2 PM relative to other time points surveyed. Mean salivary protein carbonyl concentrations did not differ among the diagnostic groups. ApoE ɛ4 carriers exhibited less temporal variation in salivary protein carbonyls relative to noncarriers. Thus, protein carbonyl content exhibits diurnal variation in adult human saliva. ApoE ɛ4 carrier status may impact oropharyngeal disease expression by attenuating the inherent diurnal variability in salivary redox homeostasis. Salivary protein carbonyls do not differentiate AD and MCI from normal individuals. In conclusion, oxidative stress has been documented in tissues and biofluids of subjects with sporadic AD and MCI. This article demonstrates that levels of protein carbonyls, a marker of oxidative stress, exhibit robust diurnal variation in the saliva of normal elderly, MCI, and AD subjects. Apolipoprotein E ɛ4 allele carrier status may attenuate this temporal variability in salivary redox homeostasis and thereby impact the natural history of oropharyngeal diseases.
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Introduction
Sporadic (nonfamilial) Alzheimer disease (AD) is the most common cause of aging-related dementia, affecting approximately 5-10% of North Americans aged 65 and as many as 30-50% of those who survive to the end of their ninth decade. It is a neurodegenerative condition characterized by progressive neuronal loss, gliosis, and the accumulation of intracellular inclusions (neurofibrillary tangles) and extracellular deposits of amyloid (senile plaques) in the basal forebrain, hippocampus, and association cortices (Selkoe 1991) . Mild cognitive impairment (MCI) is a diagnosis ascribed to elderly persons who experience gradual cognitive decline (usually memory) of at least 6 months duration that fails to meet the clinical criteria for AD or other dementia. A significant proportion of MCI subjects will progress to probable AD within a 3-5 year follow-up period (Chertkow et al. 2001) .
Although the etiology of sporadic AD remains uncertain, oxidative stress and free radical damage have been heavily implicated in the pathogenesis of this condition. Evidence of the latter include augmented oxidative modification of lipids, proteins, and nucleic acids, as well as aberrant antioxidant enzyme expression profiles and altered concentrations of lowmolecular weight antioxidant compounds in the brains of AD and MCI subjects relative neurohistologicallynormal control tissues . A burgeoning literature indicates that perturbed redox homeostasis is not confined to the AD/MCI-affected brain and cerebrospinal fluid (CSF), but is also manifest in various peripheral tissues and biofluids, including blood plasma and leukocytes, peripheral fibroblasts, and urine (Maes et al. 2006a; . These observations have provided novel insight into the systemic manifestations of AD and have fuelled interest in the development of redox-based peripheral biomarkers to assist in the diagnosis and management of the illness (Hensley et al. 1995; Schipper 2007) .
Human saliva is an eminently accessible biofluid with enormous biomarker potential (Kaufman and Lamster 2002 ). An array of oxidative damage products (e.g protein carbonyls, 8-hydroxy-2′-deoxyguanosine , 4-hydroxyalkenals, malondialdehyde) and antioxidant enzyme activities (e.g. superoxide dismutase, glutathione peroxidase, catalase) have been detected in human saliva. Importantly, changes in salivary redox homeostasis as manifested by deviations in absolute levels or expression patterns of these indices may reflect the presence and severity of various oral (e.g. periodontitis) and systemic (e.g. diabetes, inflammatory bowel disease) conditions (Arana et al. 2006; Bahar et al. 2007; Celec et al. 2005; Gorelik et al. 2007; Jahanshahi et al. 2004; Kolarzyk et al. 2006; Mashayekhi et al. 2005; Nagler et al. 2000; Reznick et al. 2006; Ryo et al. 2006; Sawamoto et al. 2005; Sculley and Langley-Evans 2003; Sugano et al. 2003; Takane et al. 2002; Tsai et al. 2005) . Changes in salivary cortisol secretion patterns (Fiocco et al. 2006; Giubilei et al. 2001; Hatfield et al. 2004; Porter et al. 2002; Scherder et al. 2006; Wolf et al. 2002; Woods and Dimond 2002) , amylase activity (Sramek et al. 1995) , and acetylcholinesterase activity (Sayer et al. 2004 ) have been documented in persons with AD or MCI, attesting to the plausibility of exploiting saliva for neurodegenerative disease biomarker discovery. However, we are unaware of any published reports on the redox status of saliva in AD/MCI, and whether salivary redox homeostasis in humans is subject to circadian fluctuations. In this study, we set out to determine whether (a) protein carbonyls, a widelyaccepted marker of protein oxidation, are elevated in the saliva of AD and MCI subjects relative to cognitively-intact controls, (b) salivary protein carbonyl contents in these groups exhibit diurnal variation, and (c) apolipoprotein E ɛ4 (apoE ɛ4) carrier status, an AD risk factor (Corder et al. 1993; Fagan and Holtzman 2000; Huang et al. 2004) , impacts salivary carbonyl concentrations or rhythmicity in the AD and MCI cohorts.
Materials and methods

Study subjects
The study was approved by the research ethics committee of the S.M.B.D. Jewish General Hospital (JGH). Written informed consent was obtained from all participants or their primary caregivers. A total of 66 subjects were enrolled in this study. Fifteen patients with sporadic (nonfamilial) AD and 21 individuals with MCI were recruited from the JGH/McGill University Memory Clinic, a tertiary care facility for the evaluation of memory loss in Montreal. All AD subjects met National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria for probable AD. MCI individuals exhibited cognitive decline (usually memory) of at least 6 months duration that did not meet dementia criteria and scores of 0.5 on the Clinical Dementia Rating scale (Hughes et al. 1982; Levy 1994 ). All AD and MCI patients underwent comprehensive neuropsychological testing by Memory Clinic neuropsychologists, as previously described (Schipper et al. 2000) . The Folstein Mini-Mental State Examination (MMSE) was administered to all subjects. Thirty cognitively normal controls were recruited among patients and staff at the JGH. Control subjects had no memory complaints and scored 28 or greater (of 30) on the MMSE and within one standard deviation of education-standardized normal values on a series of memory and attention tests. Exposure to vitamin E (400 IU or more/day), ascorbic acid (500 mg or more/day), or other antioxidants (at any dosage) was recorded in the medication records. Smokers, diabetics, and individuals suffering from significant dental, gingival, or chronic systemic inflammatory diseases were excluded from the study.
Apolipoprotein E genotyping
ApoE genotyping was performed on all AD and MCI patients in the Molecular Diagnostics Laboratory of the JGH, as previously reported (Berlin et al. 2004 ). The PCR primers and assay conditions were identical to those initially described by Hixon and Vernier (Hixson and Vernier 1990) .
Saliva collection and preparation
Whole, unstimulated saliva samples were collected at least 30 min after food or liquid ingestion in sterilized salivette tubes (SARSTEDT, Inc., Newton, NC, USA) at 8 AM, 10 AM, 2 PM, 4 PM, and 10 PM. The tubes were sealed immediately after sample collection and refrigerated at 4°C before transport to the laboratory. The saliva was centrifuged at 10,000×g for 20 min at 4°C to diminish salivary residua and viscosity. The supernatants were aliquoted and stored at −80°C prior to analysis.
Total measurement of protein carbonyls
Total carbonylated proteins were quantified in individual saliva samples using a sensitive ELISA method (Buss et al. 1997; Winterbourn and Buss 1999) , as previously performed in our laboratory (Song et al. 2006) . Oxidized bovine serum albumin (BSA; Sigma Chemical Co., St. Louis, MO, USA) served as a standard. Oxidized BSA was prepared by reacting natural BSA (50 mg/ml in PBS) with hypochlorous acid (5 mM) for 1 h at 37°C, followed by overnight dialysis against PBS at 4°C. Fully reduced BSA was prepared by reacting natural BSA (5 mg/ml in PBS) with sodium borohydride (1 mg/ml) for 30 min at room temperature, followed by slow neutralization with 2 M HCl. The carbonyl content of BSA was calibrated colorimetrically by absorbance at 375 nm (ɛ=22,000 M-1.cm-1) (Winterbourn and Buss 1999) . The standard curve was constructed by mixing varying proportions of oxidized BSA and fully reduced BSA at a constant total protein concentration (4 mg/ml). Saliva protein levels were measured using Lowry's method (Bio-Rad Laboratories Inc., Hercules, CA, USA) and adjusted to 4 mg protein/ml by dilution or speed vacuum concentration. The standards and protein samples were incubated with three volumes of 10 mM 2,4-dinitro-phenylhydrazine (2,4-DNP) in 6 M guanidine-HCl, 0.5 M potassium phosphate, pH 2.5, for 45 min at room temperature (mixing every 10-15 min). 5 μl aliquots of DNPderivatized proteins were diluted in 1 ml PBS. 200 μl of diluted DNP-derivatized proteins were adsorbed to 96-well immunoplates by incubation overnight at 4°C. Nonspecific binding was blocked with 0.1% Tween-20 in PBS. The wells were incubated with primary biotinylated anti-DNP antibody (1:1000 dilution in 0.1% Tween-20/PBS; Molecular Probes, Eugene, OR) for 1 hour at 37°C. Wells were washed and incubated with streptavidin-biotinylated horseradish peroxidase (1:3000 dilution; Amersham Bioscience, Buckinghamshire, UK) for 1 hour at room temperature. After further washing, o-phenylenediamine/peroxide solution was added for color development. The reaction was stopped after 10 min with 2.5 M sulfuric acid, and the absorbance read at 490 nm. A 6-point standard curve was generated for each plate analysis. Specific absorbance for each sample was calculated by subtracting basal absorbance of the DNP reagent from total absorbance. Protein carbonyl concentrations were expressed as nmol per mg of total protein in saliva.
Statistical procedures
Chi-square and Fisher's exact and unpaired t tests were used to compare differences between groups for categorical (e.g., gender, antioxidants, APOE ɛ4 allele) and continuous variables (e.g., age, years of education, and MMSE score), respectively. The data were presented as means ± standard errors.
The primary analysis was performed to compare protein carbonyl level measures between groups within the 14 h sampling period. Repeated measures analysis was performed using a linear mixed model (SAS PROC MIXED): subjects are random effects, while diagnostic group, time, and their interactions are fixed effects. We included covariates (age, education, and MMSE) as fixed effects. Only age was kept in the final analysis as confounder. To model the quadratic effect of time, we add time*time to the model. We noted that this term was significant (p<0.0001). The best model was selected based on Akaike's Information Criterion (AIC). The secondary analysis was performed using ANOVA (PROC GLM) comparing protein carbonyl levels measures between groups at each follow-up time. In addition, we compared the protein carbonyl levels measures between both ɛ4 carrier and noncarrier groups within the 14 h sampling period (SAS PROC MIXED) and at each follow-up time (PROC GLM). The control group was excluded from these analyses. The level of significance was set at 0.05 (two-sided) for the statistical tests. Statistical analyses were performed using SAS software version 9.1.
Results
Demographics, antioxidants, and MMSE scores
Control participants were significantly younger than the MCI and AD groups (p < 0.0001 for each comparison). Differences in mean ages between the AD and MCI groups were not significant (p=0.47). Mean years of formal education scores were lower for the AD and MCI groups relative to the control cohort (p < 0.0001 for each comparison), as commonly reported in dementia studies (Bennett et al. 2003; Pavlik et al. 2006) . Gender distribution was similar among the three groups (p=0.33), and a trend towards greater antioxidant exposure in the AD and MCI groups vs. control subjects did not achieve statistical significance (p=0.08). As anticipated, mean MMSE scores were significantly lower in the AD vs. MCI and control groups (p<0.0001) and in the MCI group relative to control values (p < 0.0001) shown in Table 1 .
Salivary protein carbonyl levels
Diagnosis and sampling time Figure 1 depicts mean salivary protein carbonyl levels in the control, MCI, and AD subjects as a function of sampling time over the course of a 14-hour period. For all three diagnostic groups, mean protein carbonyl In repeat multivariate analyses of the data (PROC MIXTE, SAS) adjusting for age, mean salivary protein carbonyl levels were found to differ significantly as a function of collection time over the 14-hour sampling period (p<0.0001) independently of diagnostic category. Overall mean salivary protein carbonyl concentrations for the control, MCI, and AD groups were, respectively, 1.80 ± 0.15, 1.93 ± 0.19, and 2.16 ± 0.22 nmol/mg protein (p=0.44).
ApoE status
One or two apoE ɛ4 alleles were present in 27.3% of the AD and 26.3% of the MCI subjects. Salivary protein carbonyls for the ApoE ɛ4 allele carriers (n=8) and noncarriers (n=22) for the 14-hour collection period are shown in Fig. 2 . Average salivary carbonyl contents exhibited peak values at 2 PM for both ɛ4 carriers (1.86±0.62 nmol/mg protein) and noncarriers (3.09±0.37 nmol/mg protein), with a trend towards higher levels in the noncarriers that did not reach statistical significance (p=0.10 in GLM). Of note, the ɛ4 carriers exhibited considerably less temporal variation in salivary protein carbonyls relative to the noncarriers over the 14-hour sampling period. Age was not a confounder in the final Apo E analysis (nonApoE ɛ4 carriers: 81.73±6.48 years vs. ApoE ɛ4 carriers: 79.34±8.61; p=0.08) and was not associated with the outcome (p=0.99).
In repeat multivariate analyses (PROC MIXTE, SAS), overall mean protein carbonyl concentrations were not different (p=0.45) between the ApoE ɛ4 carriers (1.71±0.32 nmol/mg protein) and noncarriers (2.0±0.20 nmol/mg protein). However, salivary carbonyl levels again varied significantly (p<0.0001) as a function of collection time, with peak values at 2 PM.
Discussion
A major observation in the current study was the robust diurnal variation in salivary protein carbonyl levels in well-ascertained cohorts of individuals with normal cognition, MCI, and sporadic AD. In all three groups, serial measurements performed over a 14-hour (waking) period revealed peak salivary carbonyl concentrations at 2 PM. The study design and multivariate analyses indicated that this temporal variability in salivary protein oxidation was independent of factors which could theoretically have influenced the data viz., age, gender, oral hygiene, chronic systemic illness, smoking, salivary secretagogues, recent food intake, or antioxidant exposure (Bahar et al. 2007; Hershkovich et al. 2007; Nagler et al. 2000; Sculley and LangleyEvans 2003; Zloczower et al. 2007) .
Circadian rhythms for salivary cortisol secretion and chromogranin A levels have previously been described in human saliva (Den et al. 2007; Fiocco et al. 2006; Ice et al. 2004 ). To our knowledge, this study is the first to report significant diurnal fluctuations in a marker of salivary redox homeostasis. This observation is consistent with the fact that, across the phylogenetic spectrum and in a wide range of tissues, numerous antioxidant enzymes (e.g. blood superoxide dismutase), low molecular weight antioxidant compounds (e.g. plasma uric acid, melatonin, reduced thiols), and oxidatively-generated substrates (e.g. plasma malondialdehyde, urinary 8-OHdG) exhibit strong circadian or other temporal fluctuations in amount or activity (Bridges et al. 1992a; Hardeland et al. 2003; Kanabrocki et al. 2002 Kanabrocki et al. , 2004 Kanabrocki et al. , 2000 Luo et al. 1997; Niklowitz et al. 2006; Reiter et al. 1996; Valencia et al. 2001) . Whether the afternoon peak in salivary protein carbonyls (present study) is due to diurnal deficiencies in salivary gland / orophayngeal antioxidant defenses or augmented ROS production remains unclear. Future studies assessing potential rhythmic fluctuations in a broad range of salivary (and, if feasible, salivary gland) antioxidant defenses, ROS, and oxidatively-modified protein, lipid, and nucleic acid substrates may resolve this issue. It may also be of considerable interest to determine whether susceptibility to specific oral cavity pathologies is temporally-associated with salivary redox status. From a practical point of view, the data presented herein have important implications for the design and interpretation of salivary biomarker studies. For example, diurnal variations in salivary redox homeostasis may have confounded the data sets in several published reports on the relationship of periodontal disease (and its therapy) (Sculley and Langley-Evans 2003) , cigarette smoking (Nagler et al. 2000) , oral cancer (Bahar et al. 2007) , and diabetes (Zloczower et al. 2007 ) to salivary redox indices if the timing of specimen procurement was not standardized.
As described in the introduction, free radicalmediated substrate modifications have been amply demonstrated in affected brain and in various systemic tissues (blood cells, fibroblasts) and biofluids (plasma, serum, CSF) derived from patients with sporadic AD relative to age-matched individuals without cognitive impairment (Smith et al. 1991 (Smith et al. , 1996 . Similar, and occasionally even more robust, evidence of neural and systemic oxidative stress has been garnered in subjects with MCI, a frequent preclinical harbinger of incipient AD ). Contrary to this literature, salivary protein carbonyls showed no significant variations in overall levels or temporal expression patterns among the normal, MCI, and AD persons enrolled in the current study. Thus, salivary protein carbonyls per se do not appear to express the enhanced state of oxidative stress experienced by AD and MCI subjects. These negative findings argue against the use of salivary protein carbonyls as a potential biomarker of this disease. Whether AD and MCI will register in the oxidative modification(s) of other chemical substrates in saliva, or whether salivary redox homeostasis is entirely unaffected in this disease, remains to be determined.
The presence of one or two apoE ɛ4 alleles, a risk factor for the development of sporadic AD (Corder et al. 1993; Fagan and Holtzman 2000; Huang et al. 2004) , did not significantly impact average salivary protein carbonyl levels in the AD and MCI cohorts. However, the temporal variation in salivary protein carbonyl concentrations over the 14-hour sampling period appeared to be dampened in ɛ4 carriers relative to the noncarriers. If confirmed in larger studies, these findings would implicate apoE genotype as a novel and potentially important regulator of temporal protein oxidation profiles in human saliva. Such a conclusion would not be altogether surprising given the known influence of apoE status on redox homeostasis in a host of mammalian neural and systemic tissues (Biswas et al. 2005; Chan and Shea 2006; Folkmann et al. 2007; Jofre-Monseny et al. 2007; Mazur-Kolecka et al. 2006) . In this regard, it may prove interesting to determine whether the development or severity of oral pathologies linked to oxidative damage in humans, such as periodontitis (Mashayekhi et al. 2005; Sawamoto et al. 2005; Sculley and Langley-Evans 2003; Takane et al. 2002; Tsai et al. 2005) or local neoplasms (Bahar et al. 2007; Hershkovich et al. 2007) , are influenced by the apoE genotype.
The data reported herein provide evidence for the existence of robust temporal variations in levels of salivary protein oxidation in human saliva over a 14-hour (waking) period. These observations raise the intriguing possibility that various oral pathologies and their responsiveness to therapeutic interventions may be impacted by diurnal (possibly circadian) fluctuations in salivary redox homeostasis. Absolute concentrations and temporal expression patterns of salivary protein carbonyls did not differ among AD, MCI, and cognitively-normal subjects thereby discounting salivary protein carbonyls as a viable biomarker of this common neurodegenerative disorder. Finally, apoE ɛ4 status affected the temporal rhythmicity of salivary protein oxidation, raising the possibility that the former may bear on the natural history of redox-related oropharyngeal lesions.
